Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner
2003 National Healthcare Quality Report

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Percent of children 19-35 months who received 4 doses of DPaT vaccine.

Measure Source

Healthy People 2010, measure 14-22a.

Tables

1.53a Percent of children age 19-35 months who received 4 doses of DPaT vaccine, United States, 2001.

1.53b Percent of children age 19-35 months who received 4 doses of DPaT vaccine, United States, 2000.

1.53c Percent of children age 19-35 months who received 4 doses of DPaT vaccine, United States, 1999.

1.53d Percent of children age 19-35 months who received 4 doses of DPaT vaccine, United States, 1998.

1.53e Percent of children age 19-35 months who received 4 doses of DPaT vaccine, by state, 2001.

1.53f Percent of children age 19-35 months who received 4 doses of DPaT vaccine, by state, 2000.

Data Source

Centers for Disease Control and Prevention, National Center for Health Statistics and National Immunization Program, National Immunization Survey.

Denominator

U.S. civilian, noninstitutionalized population, children, age 19 to 35 months.

Numerator

Number of children, age 19 to 35 months, receiving at least four or more doses of the combination of diphtheria, tetanus, and acellular pertussis antigens.

Comments

Statistical adjustments are made to minimize bias due to (1) lower coverage among children living in households without telephones, (2) discrepancies between vaccinations reported by household compared with immunization providers, and (3) differences in race/ethnic population distribution in sample compared to race/ethnic population distribution at birth.

This measure is a modification of the comparable Healthy People 2000 objective 20.11, which tracked the number of children, age 19 to 35 months, receiving three or more doses of the combination of diphtheria, tetanus, and pertussis antigens (DTP).

This baseline measure tracks the number of children, age 19 to 35 months, receiving four or more doses of the combination of diphtheria, tetanus, and acellular pertussis antigens (DTaP) as well as those children who received the combination of diphtheria, tetanus, and pertussis antigens (DTP).

Return to Previous Measure
Return to Measures Specifications Appendix
Proceed to Next Measure
Return to Contents

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care